If a court ruling made late on Friday holds up, the battle for market share in the U.S. between Edwards Lifesciences' (NYSE: EW ) Sapien family of transcatheter heart valves and Medtronic's (NYSE: MDT )
CoreValve may be over before it begins. In a rare move for the
med-tech industry, a judge granted a motion for a preliminary injunction
against sales of the CoreValve that would effectively put Medtronic on
ice until at least 2016. Medtronic is going to fight this decision, but
it definitely seems likely to reignite optimism for Edwards' position in
this market.
Read the full article here:
Edwards Lifesciences Corp Scores A Potentially Major Legal Ruling Against Medtronic
No comments:
Post a Comment